Trial Profile
Thiotepa dose finding study for allogeneic SCT in adult patients with high risk haematological malignancies.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2012
Price :
$35
*
At a glance
- Drugs Thiotepa (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 17 Aug 2011 New trial record